Search

GE HealthCare Technologies

Open

SectorHealthcare

73.69 -0.53

Overview

Share price change

24h

Current

Min

73.98

Max

75.09

Key metrics

By Trading Economics

Income

163M

574M

Sales

164M

5.3B

P/E

Sector Avg

16.988

57.371

EPS

1.13

Dividend yield

0.19

Profit margin

10.84

Employees

54,000

EBITDA

198M

953M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+5.68% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.19%

2.23%

Next Earnings

28 paź 2026

Next Dividend date

13 lis 2026

Next Ex Dividend date

23 paź 2026

Market Stats

By TradingEconomics

Market Cap

5.1B

33B

Previous open

74.22

Previous close

73.69

News Sentiment

By Acuity

28%

72%

80 / 340 Ranking in Healthcare

GE HealthCare Technologies Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 sie 2026, 20:06 UTC

News

GE Healthcare Technologies appointed William Grogan as CFO, effective September 2026. BTIG reiterated its Buy rating with a $79 price target. Shares are higher since Tuesday's close.

18 sie 2026, 23:51 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, reaching above Tuesday's close despite elevated bond yields and ongoing inflation concerns.

17 sie 2026, 23:11 UTC

GE Healthcare Technologies shares are higher in after-market trading, reaching a notable increase while remaining above its 20-day moving average. No specific news was identified.

14 sie 2026, 19:46 UTC

GE Healthcare Technologies is trading roughly flat, with no specific news identified. Shares peaked earlier but have since settled back down.

13 sie 2026, 23:46 UTC

GE Healthcare Technologies shares declined in after-market trading, reflecting a slight drop since Thursday's close. The stock remained above its 20-day moving average.

12 sie 2026, 23:26 UTC

News

Trian Fund Management increased its stake in GE Healthcare Technologies to 3.1 million shares, contributing to a modest rise in after-market hours.

11 sie 2026, 20:06 UTC

GE Healthcare Technologies shares are lower today amid broader market declines. The stock remains above its 20-day moving average despite earlier gains.

10 sie 2026, 19:16 UTC

GE Healthcare Technologies shares are higher today, reflecting gains since Friday's close. No specific news was identified to explain the price movement.

7 sie 2026, 23:36 UTC

No specific news for GE Healthcare Technologies. The stock traded roughly flat after-market, remaining near the upper end of its one-month range.

6 sie 2026, 19:46 UTC

GE Healthcare Technologies remains roughly flat as price fluctuations continue. The stock trades near the upper end of its one-month range and above its moving average.

5 sie 2026, 19:56 UTC

News

GE Healthcare reported strong Q2 results with $5.30 billion in revenue and adjusted EPS of $1.13, but shares are trading lower since Tuesday's close.

4 sie 2026, 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

3 sie 2026, 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

31 lip 2026, 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

30 lip 2026, 22:31 UTC

News

GE Healthcare Technologies reported Q2 revenue of $5.30 billion, but shares are trading lower after highlighting challenges in the Patient Care Solutions segment.

29 lip 2026, 23:21 UTC

GE Healthcare shares are lower in after-market hours, reflecting a decline after briefly recovering earlier in the session. No specific news was identified.

28 lip 2026, 23:41 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, showing volatility with no specific news identified to explain the movement.

27 lip 2026, 23:16 UTC

GE Healthcare shares are trading higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

24 lip 2026, 20:03 UTC

Event
News

GE Healthcare shares decline as CFO Jay Saccaro steps down amid preliminary Q2 results showing revenue growth to $5.295 billion.

23 lip 2026, 23:41 UTC

Event
News

GE Healthcare appointed George Newcomb as interim CFO and reported $5.30 billion in second-quarter revenue, with shares higher in after-market trading.

22 lip 2026, 23:31 UTC

GE Healthcare Technologies shares moved higher in after-market trading, despite earlier fluctuations. Broader market dynamics include rising crude oil prices amid U.S.-Iran tensions.

21 lip 2026, 23:46 UTC

GE Healthcare shares are higher in after-market hours amid positive market sentiment from recent earnings reports, though they remain below the 20-day moving average.

20 lip 2026, 16:31 UTC

News

GE Healthcare Technologies has launched MIM Anyware, enhancing remote access to its software portfolio. Shares are trading higher, breaking from a recent upward trend.

Peer Comparison

Price change

GE HealthCare Technologies Forecast

Price Target

By TipRanks

5.68% upside

12 Months Forecast

Average 79.07 USD  5.68%

High 92 USD

Low 70 USD

Based on 14 Wall Street analysts offering 12 month price targets forGE HealthCare Technologies - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

9

Buy

5

Hold

0

Sell

Sentiment

By Acuity

80 / 340 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
help-icon Live chat